Anixa’s Ovarian Cancer Trial Progress: Promising Results
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
- Latest
- Trending
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
Greenidge Generation Holdings secures $6 million investment from Armistice Capital to drive growth and expand its power centers and bitcoin ...
The stock market continues to rise with the support of the Federal Reserve's financial aid. The Nasdaq and S&P 500 ...
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
BofA Securities initiates coverage on Palmer Square Capital BDC with a Neutral rating. Market valuation reflects risks and rewards, potential ...
Abacus Life has announced the pricing of a $25 million public offering to refinance debt. With strong financial growth, the ...
ContextLogic, the company behind Wish, will sell most of its assets to Qoo10 for $173M in cash. This move aims ...
Tonix Pharmaceuticals receives FDA clearance for its OASIS trial, evaluating the efficacy of TNX-102 SL in treating acute stress reactions ...
Employers can now match a percentage of an employee's student loan payment and direct it into a retirement plan under ...
Truist Securities raises price target for Shopify shares ahead of earnings report, predicting strong growth potential. Market sentiment is positive.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.